SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-124711
Filing Date
2021-04-21
Accepted
2021-04-21 16:13:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d296654ddefa14a.htm DEFA14A 15988
2 GRAPHIC g296654g14e73.jpg GRAPHIC 264803
3 GRAPHIC g296654g25k32.jpg GRAPHIC 353237
  Complete submission text file 0001193125-21-124711.txt   868584
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36076 | Film No.: 21841688
SIC: 2836 Biological Products, (No Diagnostic Substances)